Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness

Melissa C. Whiteman, Jason A. Wicker, Richard M. Kinney, Claire Y H Huang, Tom Solomon, Alan Barrett

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

West Nile virus (WNV), like all members of the Japanese encephalitis (JE) serogroup except JE virus, contains three N-linked glycosylation (N-X-S/T) sites in the NS1 protein at asparagine residues NS1 130, NS1 175 and NS1 207. Previously we showed that the ablation of these glycosylation sites in WNV, by substitution of asparagine for alanine, attenuated mouse neuroinvasiveness; however, full attenuation was not achieved and the virus retained a neurovirulence phenotype. Sequence of viral RNA extracted from mouse brains revealed a reversion at the NS1 130 site in some mice that succumbed to the attenuated NS1 130A/175A/207A strain. Here, we further attenuated WNV by mutating the asparagine to serine or glutamine in addition to mutating other residues in the NS1 130-132 glycosylation motif. These mutants proved to further attenuate WNV for both neuroinvasiveness and neurovirulence in mice. NS1 130-132QQA/175A/207A, the most attenuated mutant virus, showed modest changes in infectivity titers versus the parental strain, was not temperature sensitive, and did not show reversion in mice. Mutant virus was completely attenuated for neuroinvasiveness after intraperitoneal inoculation with >1,000,000 PFU, and mice were protected against lethal challenge. Overall, we showed that changing the asparagine of the NS1 130 glycosylation motif to a serine or glutamine attenuated WNV further than the asparagine to alanine substitution. Further, mutating all three of the amino acids of the NS1 130-132 glycosylation motif (NTT-QQA) along with NS1 175 and NS1 207 asparagine to alanine mutations gave the most stable and attenuated strain.

Original languageEnglish (US)
Pages (from-to)9702-9710
Number of pages9
JournalVaccine
Volume29
Issue number52
DOIs
StatePublished - Dec 6 2011

Fingerprint

West Nile virus
Asparagine
asparagine
glycosylation
Glycosylation
Amino Acids
amino acids
mice
Alanine
alanine
proteins
Viruses
Glutamine
glutamine
viruses
mutants
serine
Serine
Japanese Encephalitis Virus
Japanese Encephalitis

Keywords

  • Attenuation
  • Glycosylation
  • NS1
  • West Nile virus

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness. / Whiteman, Melissa C.; Wicker, Jason A.; Kinney, Richard M.; Huang, Claire Y H; Solomon, Tom; Barrett, Alan.

In: Vaccine, Vol. 29, No. 52, 06.12.2011, p. 9702-9710.

Research output: Contribution to journalArticle

Whiteman, Melissa C. ; Wicker, Jason A. ; Kinney, Richard M. ; Huang, Claire Y H ; Solomon, Tom ; Barrett, Alan. / Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness. In: Vaccine. 2011 ; Vol. 29, No. 52. pp. 9702-9710.
@article{cdad0f1b82cc434aaa38b76e03950c9d,
title = "Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness",
abstract = "West Nile virus (WNV), like all members of the Japanese encephalitis (JE) serogroup except JE virus, contains three N-linked glycosylation (N-X-S/T) sites in the NS1 protein at asparagine residues NS1 130, NS1 175 and NS1 207. Previously we showed that the ablation of these glycosylation sites in WNV, by substitution of asparagine for alanine, attenuated mouse neuroinvasiveness; however, full attenuation was not achieved and the virus retained a neurovirulence phenotype. Sequence of viral RNA extracted from mouse brains revealed a reversion at the NS1 130 site in some mice that succumbed to the attenuated NS1 130A/175A/207A strain. Here, we further attenuated WNV by mutating the asparagine to serine or glutamine in addition to mutating other residues in the NS1 130-132 glycosylation motif. These mutants proved to further attenuate WNV for both neuroinvasiveness and neurovirulence in mice. NS1 130-132QQA/175A/207A, the most attenuated mutant virus, showed modest changes in infectivity titers versus the parental strain, was not temperature sensitive, and did not show reversion in mice. Mutant virus was completely attenuated for neuroinvasiveness after intraperitoneal inoculation with >1,000,000 PFU, and mice were protected against lethal challenge. Overall, we showed that changing the asparagine of the NS1 130 glycosylation motif to a serine or glutamine attenuated WNV further than the asparagine to alanine substitution. Further, mutating all three of the amino acids of the NS1 130-132 glycosylation motif (NTT-QQA) along with NS1 175 and NS1 207 asparagine to alanine mutations gave the most stable and attenuated strain.",
keywords = "Attenuation, Glycosylation, NS1, West Nile virus",
author = "Whiteman, {Melissa C.} and Wicker, {Jason A.} and Kinney, {Richard M.} and Huang, {Claire Y H} and Tom Solomon and Alan Barrett",
year = "2011",
month = "12",
day = "6",
doi = "10.1016/j.vaccine.2011.09.036",
language = "English (US)",
volume = "29",
pages = "9702--9710",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "52",

}

TY - JOUR

T1 - Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness

AU - Whiteman, Melissa C.

AU - Wicker, Jason A.

AU - Kinney, Richard M.

AU - Huang, Claire Y H

AU - Solomon, Tom

AU - Barrett, Alan

PY - 2011/12/6

Y1 - 2011/12/6

N2 - West Nile virus (WNV), like all members of the Japanese encephalitis (JE) serogroup except JE virus, contains three N-linked glycosylation (N-X-S/T) sites in the NS1 protein at asparagine residues NS1 130, NS1 175 and NS1 207. Previously we showed that the ablation of these glycosylation sites in WNV, by substitution of asparagine for alanine, attenuated mouse neuroinvasiveness; however, full attenuation was not achieved and the virus retained a neurovirulence phenotype. Sequence of viral RNA extracted from mouse brains revealed a reversion at the NS1 130 site in some mice that succumbed to the attenuated NS1 130A/175A/207A strain. Here, we further attenuated WNV by mutating the asparagine to serine or glutamine in addition to mutating other residues in the NS1 130-132 glycosylation motif. These mutants proved to further attenuate WNV for both neuroinvasiveness and neurovirulence in mice. NS1 130-132QQA/175A/207A, the most attenuated mutant virus, showed modest changes in infectivity titers versus the parental strain, was not temperature sensitive, and did not show reversion in mice. Mutant virus was completely attenuated for neuroinvasiveness after intraperitoneal inoculation with >1,000,000 PFU, and mice were protected against lethal challenge. Overall, we showed that changing the asparagine of the NS1 130 glycosylation motif to a serine or glutamine attenuated WNV further than the asparagine to alanine substitution. Further, mutating all three of the amino acids of the NS1 130-132 glycosylation motif (NTT-QQA) along with NS1 175 and NS1 207 asparagine to alanine mutations gave the most stable and attenuated strain.

AB - West Nile virus (WNV), like all members of the Japanese encephalitis (JE) serogroup except JE virus, contains three N-linked glycosylation (N-X-S/T) sites in the NS1 protein at asparagine residues NS1 130, NS1 175 and NS1 207. Previously we showed that the ablation of these glycosylation sites in WNV, by substitution of asparagine for alanine, attenuated mouse neuroinvasiveness; however, full attenuation was not achieved and the virus retained a neurovirulence phenotype. Sequence of viral RNA extracted from mouse brains revealed a reversion at the NS1 130 site in some mice that succumbed to the attenuated NS1 130A/175A/207A strain. Here, we further attenuated WNV by mutating the asparagine to serine or glutamine in addition to mutating other residues in the NS1 130-132 glycosylation motif. These mutants proved to further attenuate WNV for both neuroinvasiveness and neurovirulence in mice. NS1 130-132QQA/175A/207A, the most attenuated mutant virus, showed modest changes in infectivity titers versus the parental strain, was not temperature sensitive, and did not show reversion in mice. Mutant virus was completely attenuated for neuroinvasiveness after intraperitoneal inoculation with >1,000,000 PFU, and mice were protected against lethal challenge. Overall, we showed that changing the asparagine of the NS1 130 glycosylation motif to a serine or glutamine attenuated WNV further than the asparagine to alanine substitution. Further, mutating all three of the amino acids of the NS1 130-132 glycosylation motif (NTT-QQA) along with NS1 175 and NS1 207 asparagine to alanine mutations gave the most stable and attenuated strain.

KW - Attenuation

KW - Glycosylation

KW - NS1

KW - West Nile virus

UR - http://www.scopus.com/inward/record.url?scp=82555176522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82555176522&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2011.09.036

DO - 10.1016/j.vaccine.2011.09.036

M3 - Article

C2 - 21945257

AN - SCOPUS:82555176522

VL - 29

SP - 9702

EP - 9710

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 52

ER -